Charles, this stock is on an upward trend toward
the high teens. A downward fractional move is NOT
something to write about or worry about since that
is absolutely normal as part of any upward trend.
Remember, this stock was trading between 8 3/4 and
9 at the beginning of the year. Don't worry about
a fractional move on normal volume. You should see
volume pick up to 400-500K this week or next and a
share price of 11-12 or higher, all which will
confirm the bullish sentiment on NABI.
Since you asked for news, I'll oblige and give you
the latest information from a Standard and Poor's
report I obtained yesterday. Of 7 analysts
covering NABI, 5 rate it a BUY (highest S&P
ranking), 1 rates it a BUY/HOLD and 1 rates it a
HOLD. The Average Qualitative Opinion (AQO) on
NABI is a 1.64 out of a possible 2.00, which places
it at the extreme end of the BUY range where a
score of 1.00 to 2.00 is a BUY. The range of AOQ
is from -2.00 to +2.00; very few stocks rate as
high as NABI's 1.64. You should also know that
there is fast-growing analyst interest in NABI,
which was covered by only 2 analysts in February
1996 and is now covered by 7 analysts. As more
analysts cover NABI and more issue BUYs, the stock
price necessarily goes up as those analysts tell
their customers to buy NABI.
S&P notes that in the first 3 quarters of FY 96,
NABI's net sales increased 20% year to year, due to
increased plasma volume and growing worldwide
demand for high value specialty plasma products.
They noted that profit margins widened on the
higher volume. Excluding a non-recurring charge,
NABI earned .09 last quarter, which is also the
consensus estimate for the latest quarter. The
fact that they made .09 last quarter (excluding
charge) and that NABI has already said that its
plasma supply is sold-out for 1997 plus intact
strong demand for H-BIG, suggests to me earnings
will, at least, meet expectations and will probably
exceed them. Thus, when NABI releases its earnings
next week and shows that it made anywhere between
.09 to .12 per share, the Street will compare that
figure with earnings for the past 7 quarters (which
were .03, .05, .04, (.31), (.08), (.08), (0.05) and
the stock will immediately move to the mid-teens
and gradually continue rising to the high teens.
At the present time, I frankly do not see a better
or safer stock than NABI. NABI's risk/reward ratio
is among the best. The reason that you don't hear
about negative news here is that there isn't any at
the present time.
|
